Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 557741 - 557754 out of 557754 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (V09HX) other diagnostic radiopharmaceuticals for inflammation and infection detection | NETSPOT 40MCG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (V09HX) other diagnostic radiopharmaceuticals for inflammation and infection detection | NETSPOT 40MCG/VIL INJ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NovartisPharmaceuticalsCorporation |
| USA | (V09IX14) gallium (68ga) gozetotide | LOCAMETZ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Radionuclide Imaging | NovartisPharmaceuticalsCorporation |
| USA | (V09IX14) gallium (68ga) gozetotide | LOCAMETZ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Radionuclide Imaging | NovartisPharmaceuticalsCorporation |
| USA | (V09IX14) gallium (68ga) gozetotide | LOCAMETZ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Radionuclide Imaging | NovartisPharmaceuticalsCorporation |
| USA | (V09IX14) gallium (68ga) gozetotide | LOCAMETZ | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Radionuclide Imaging | NovartisPharmaceuticalsCorporation |
| USA | (V10XX03) radium (223ra) dichloride | XOFIGO (PRICE PER Microcurie) | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (V10XX03) radium (223ra) dichloride | XOFIGO (PRICE PER Microcurie) | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms | BayerHealthCarePharmaceuticals,Inc. |
| USA | (V10XX04) lutetium (177lu) oxodotreotide | LUTATHERA | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | NovartisPharmaceuticalsCorporation |
| USA | (V10XX04) lutetium (177lu) oxodotreotide | LUTATHERA | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | NovartisPharmaceuticalsCorporation |
| USA | (V10XX05) lutetium (177lu) vipivotide tetraxetan | PLUVICTO | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | NovartisPharmaceuticalsCorporation |
| USA | (V10XX05) lutetium (177lu) vipivotide tetraxetan | PLUVICTO | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | NovartisPharmaceuticalsCorporation |
| USA | (V10XX05) lutetium (177lu) vipivotide tetraxetan | PLUVICTO | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | NovartisPharmaceuticalsCorporation |
| USA | (V10XX05) lutetium (177lu) vipivotide tetraxetan | PLUVICTO | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Prostatic Neoplasms, Castration-Resistant | NovartisPharmaceuticalsCorporation |
Pages
